Valuation: Camurus AB

Market Cap 36.84B 3.8B 3.33B 3.08B 2.83B 5.35B 367B 5.43B 14.44B 179B 14.28B 13.97B 618B P/E 2026 *
38.8x
P/E 2027 * 25x
Enterprise Value 32.27B 3.33B 2.92B 2.7B 2.48B 4.68B 321B 4.76B 12.65B 157B 12.51B 12.24B 542B EV / Sales 2026 *
11.3x
EV / Sales 2027 * 8.19x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.51%
1 week+15.16%
Current month+9.46%
1 month+19.27%
3 months+9.75%
6 months-8.57%
Current year+0.49%
1 week 568
Extreme 568
645
1 month 505
Extreme 505
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
2/27/26 A Sell

Chief Executive Officer

9,950 0.0166%
2/27/26 A Sell

Chief Executive Officer

1,500 0.0025%
2/27/26 A Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%+15.16%-11.82%+108.42% 3.8B
-2.73%-2.96%+48.62%+147.27% 1,023B
-1.67%-3.47%+52.00%+47.77% 599B
-0.44%+2.17%+33.88%+78.20% 448B
-0.75%+0.30%+28.32%+21.15% 326B
-1.52%-1.19%+33.38%+35.35% 278B
-1.70%-1.82%+20.26%+15.74% 258B
-0.58%+1.11%-20.89%-40.59% 222B
-0.58%+1.03%+23.55%+56.14% 197B
-0.80%+1.38%+23.09%+66.64% 165B
Average -0.83%+1.17%+23.04%+53.61% 351.89B
Weighted average by Cap. -0.88%-1.17%+35.11%+70.62%

Financials

2026 *2027 *
Net sales 2.85B 294M 258M 238M 219M 413M 28.34B 420M 1.12B 13.86B 1.1B 1.08B 47.77B 3.79B 391M 343M 317M 292M 550M 37.73B 559M 1.49B 18.46B 1.47B 1.44B 63.6B
Net income 968M 99.94M 87.59M 80.97M 74.47M 141M 9.64B 143M 380M 4.72B 375M 367M 16.25B 1.45B 150M 131M 122M 112M 211M 14.46B 214M 570M 7.08B 563M 551M 24.38B
Net Debt -4.56B -471M -413M -382M -351M -662M -45.42B -673M -1.79B -22.23B -1.77B -1.73B -76.57B -5.81B -599M -525M -486M -447M -843M -57.8B -856M -2.28B -28.28B -2.25B -2.2B -97.44B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
20/07/26 SEK 619.00 -1.51% 47,024
17/07/26 SEK 628.50 -1.64% 67,377
16/07/26 SEK 639.00 +3.90% 109,880
15/07/26 SEK 615.00 +16.81% 380,833
14/07/26 SEK 526.50 -2.05% 69,616
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
619.00SEK
Average target price
776.75SEK
Spread / Average Target
+25.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock